Phase I/II dose escalation study of recombinant human interleukin‐11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study*Mitchell S. Cairo, Gregory H. Reaman, Olga Bessmertny et al.|British Journal of Haematology|2004Cited by 32